BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32269723)

  • 1. Role of m
    He Y; Yu X; Li J; Zhang Q; Zheng Q; Guo W
    Am J Transl Res; 2020; 12(3):912-922. PubMed ID: 32269723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
    Yang X; Yang F; Lan L; Wen N; Li H; Sun X
    Front Genet; 2022; 13():972043. PubMed ID: 36105093
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 5. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Pan J; Huang Z; Xu Y
    Front Oncol; 2021; 11():657466. PubMed ID: 34195072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker.
    Cui M; Qu F; Wang L; Liu X; Yu J; Tang Z; Cheng D
    Cancer Biomark; 2022; 33(3):389-400. PubMed ID: 34744073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma.
    Xue M; Shi Q; Zheng L; Li Q; Yang L; Zhang Y
    Am J Transl Res; 2020; 12(10):6841-6852. PubMed ID: 33194076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
    Front Oncol; 2020; 10():780. PubMed ID: 32587825
    [No Abstract]   [Full Text] [Related]  

  • 9. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Omic Analyses of the m
    Xue C; Zhao Y; Li G; Li L
    Front Oncol; 2021; 11():633415. PubMed ID: 34367948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering the Association Between m
    Gu X; Zhou H; Chu Q; Zheng Q; Wang J; Zhu H
    Front Cell Dev Biol; 2021; 9():727935. PubMed ID: 34589490
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis.
    Liu P; Wei J; Mao F; Xin Z; Duan H; Du Y; Wang X; Li Z; Qian J; Yao J
    Front Oncol; 2021; 11():641487. PubMed ID: 34094926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
    Chen Y; Zhao J; Jiao Z; Wang W; Wang D; Yu X; Shi Z; Ge N; Pan Q; Xia J; Niu W; Zhao R; Zhang X; Du W
    BMC Cancer; 2018 Dec; 18(1):1240. PubMed ID: 30537941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
    Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
    J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma.
    Liu Y; Zheng S; Wang T; Fang Z; Kong J; Liu J
    Front Cell Dev Biol; 2022; 10():842220. PubMed ID: 35252205
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing.
    Zhang Z; Cao C; Zhou CL; Li X; Miao C; Shen L; Singla RK; Lu X
    Transl Oncol; 2023 Oct; 36():101741. PubMed ID: 37523897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Alterations and Transcriptional Expression of m
    Zhu GQ; Yu L; Zhou YJ; Du JX; Dong SS; Wu YM; Shi YH; Zhou J; Fan J; Dai Z
    Front Oncol; 2020; 10():900. PubMed ID: 32850303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.